Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Epidemiology of respiratory infections among adults in Qatar (2012-2017).

Al-Romaihi HE, Smatti MK, Ganesan N, Nadeem S, Farag E, Coyle PV, Nader JD, Al-Khatib HA, Elmagboul EB, Al Dhahry S, Al-Marri SA, Al Thani AA, Al Khal A, Al Maslamani MA, Yassine HM.

PLoS One. 2019 Jun 13;14(6):e0218097. doi: 10.1371/journal.pone.0218097. eCollection 2019.

2.

Demographics and Epidemiology of Hepatitis B in the State of Qatar: A Five-Year Surveillance-Based Incidence Study.

Al Romaihi HE, Ganesan N, Farag EA, Smatti MK, Nasrallah GK, Himatt SM, Derbala MF, Alshamali M, Mahadoon LK, Khogali HS, Sallam M, Al Thani AA, Al Thani M, Al Kaabi S, Yassine HM.

Pathogens. 2019 May 21;8(2). pii: E68. doi: 10.3390/pathogens8020068.

3.

Hepatitis B Virus Molecular Epidemiology, Host-Virus Interaction, Coinfection, and Laboratory Diagnosis in the MENA Region: An Update.

Al-Sadeq DW, Taleb SA, Zaied RE, Fahad SM, Smatti MK, Rizeq BR, Al Thani AA, Yassine HM, Nasrallah GK.

Pathogens. 2019 May 11;8(2). pii: E63. doi: 10.3390/pathogens8020063. Review.

4.

Epidemiological, Molecular, and Clinical Features of Norovirus Infections among Pediatric Patients in Qatar.

Mathew S, Alansari K, K Smatti M, Zaraket H, Al Thani AA, Yassine HM.

Viruses. 2019 Apr 29;11(5). pii: E400. doi: 10.3390/v11050400.

5.

Epidemiological and genetic characterization of pH1N1 and H3N2 influenza viruses circulated in MENA region during 2009-2017.

Al Khatib HA, Al Thani AA, Gallouzi I, Yassine HM.

BMC Infect Dis. 2019 Apr 11;19(1):314. doi: 10.1186/s12879-019-3930-6.

6.

Expression profile of MicroRNA: An Emerging Hallmark of Cancer.

Zaheer U, Faheem M, Qadri I, Begum N, Yassine HM, Al Thani AA, Mathew S.

Curr Pharm Des. 2019 Mar 25. doi: 10.2174/1386207322666190325122821. [Epub ahead of print]

PMID:
30914015
7.

Comparative Serological Study for the Prevalence of Anti-MERS Coronavirus Antibodies in High- and Low-Risk Groups in Qatar.

Al Kahlout RA, Nasrallah GK, Farag EA, Wang L, Lattwein E, Müller MA, El Zowalaty ME, Al Romaihi HE, Graham BS, Al Thani AA, Yassine HM.

J Immunol Res. 2019 Feb 18;2019:1386740. doi: 10.1155/2019/1386740. eCollection 2019.

8.

Mixed Viral-Bacterial Infections and Their Effects on Gut Microbiota and Clinical Illnesses in Children.

Mathew S, Smatti MK, Al Ansari K, Nasrallah GK, Al Thani AA, Yassine HM.

Sci Rep. 2019 Jan 29;9(1):865. doi: 10.1038/s41598-018-37162-w.

9.

Viral-Induced Enhanced Disease Illness.

Smatti MK, Al Thani AA, Yassine HM.

Front Microbiol. 2018 Dec 5;9:2991. doi: 10.3389/fmicb.2018.02991. eCollection 2018. Review.

10.

The Dual Specificity Role of Transcription Factor FOXO in Type 2-diabetes and Cancer.

Fatima K, Mathew S, Faheem M, Mehmood T, Yassine HM, Al Thani AA, Abdel-Hafiz H, Al Ghamdy K, Qadri I.

Curr Pharm Des. 2018;24(24):2839-2848. doi: 10.2174/1381612824666180911114210.

PMID:
30205794
11.

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.

Mathew S, Al Thani AA, Yassine HM.

PLoS One. 2018 Sep 4;13(9):e0203148. doi: 10.1371/journal.pone.0203148. eCollection 2018.

12.

Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population.

Eltai NO, Al Thani AA, Al-Ansari K, Deshmukh AS, Wehedy E, Al-Hadidi SH, Yassine HM.

Antimicrob Resist Infect Control. 2018 Jul 28;7:90. doi: 10.1186/s13756-018-0381-6. eCollection 2018.

13.

Evolution and dynamics of the pandemic H1N1 influenza hemagglutinin protein from 2009 to 2017.

Al Khatib HA, Al Thani AA, Yassine HM.

Arch Virol. 2018 Nov;163(11):3035-3049. doi: 10.1007/s00705-018-3962-z. Epub 2018 Jul 31.

PMID:
30066273
14.

Prevalence of antibiotic resistant Escherichia coli isolates from fecal samples of food handlers in Qatar.

Eltai NO, Yassine HM, Al Thani AA, Abu Madi MA, Ismail A, Ibrahim E, Alali WQ.

Antimicrob Resist Infect Control. 2018 Jun 26;7:78. doi: 10.1186/s13756-018-0369-2. eCollection 2018.

15.

Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches.

Taleb SA, Al Thani AA, Al Ansari K, Yassine HM.

Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1817-1827. doi: 10.1007/s10096-018-3289-4. Epub 2018 Jun 6. Review.

PMID:
29876771
16.

Antibiotic Resistance Profile of Commensal Escherichia coli Isolated from Broiler Chickens in Qatar.

Eltai NO, Abdfarag EA, Al-Romaihi H, Wehedy E, Mahmoud MH, Alawad OK, Al-Hajri MM, Al Thani AA, Yassine HM.

J Food Prot. 2018 Feb;81(2):302-307. doi: 10.4315/0362-028X.JFP-17-191.

PMID:
29369690
17.

Improving Influenza Vaccination Rate among Primary Healthcare Workers in Qatar.

Elawad KH, Farag EA, Abuelgasim DA, Smatti MK, Al-Romaihi HE, Al Thani M, Al Mujalli H, Shehata Z, Alex M, Al Thani AA, Yassine HM.

Vaccines (Basel). 2017 Oct 10;5(4). pii: E36. doi: 10.3390/vaccines5040036.

18.

Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.

El Zowalaty ME, Al Thani AA, Webster TJ, El Zowalaty AE, Schweizer HP, Nasrallah GK, Marei HE, Ashour HM.

Future Microbiol. 2015;10(10):1683-706. doi: 10.2217/fmb.15.48. Epub 2015 Oct 6. Review.

PMID:
26439366

Supplemental Content

Loading ...
Support Center